GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
7.16
-0.33 (-4.41%)
At close: Sep 18, 2026, 4:00 PM EDT
7.30
+0.14 (1.96%)
After-hours: Sep 18, 2026, 7:55 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $12.92 million as of September 18, 2026. Its market cap has increased by 361.41% in one year.
Market Cap
12.92M
Enterprise Value
7.96M
1-Year Change
361.41%
Ranking
Category
Stock Price
$7.16
ChartMarket Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $12.92M, a decrease of -84.47%. That is a compound annual growth rate of -19.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 12.90M | 55.42% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 14.80M |
| Quoin Pharmaceuticals | 14.08M |
| Vyome Holdings | 13.76M |
| Adial Pharmaceuticals | 13.68M |
| CalciMedica | 13.45M |
| BioVie | 13.43M |
| Pluri | 13.33M |
| Moolec Science | 12.96M |